Technology · Synthetic biology investment
Investment in synthetic biology in Germany reached 120 M $ in 2026, ranking the country 19 out of 197. Funding is concentrated in Munich and Berlin, where startups like Theraptosis and T-knife develop synthetic gene circuits for cancer therapy. The German approach is pragmatic: investors favor projects with clear industrial applications, such as enzyme and bioplastic production.
Data for 2026 · unit: $
Position
#19 / 197
Germany world ranking
Country position on the scale from last to first place for this indicator.
DE
#19
#197#1
Trend
Change over time
Change in indicator over the available period.
10 M
2000
50 M
2010
100 M
2020
200 M
2025
120 M
2026
Values — $
Comparison
Top countries by Synthetic biology investment
Where Germany stands in the world ranking.
1
CNChina
6 B
2
RURussia
2.5 B
2
USUSA
2.5 B
4
GBUnited Kingdom
800 M
5
CACanada
700 M
6
DKDenmark
350 M
7
NZNew Zealand
300 M
7
AUAustralia
300 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Synthetic biology investment in Germany — how much?
Based on 2026 data — 120 M $. This is rank #19 out of 197 countries.
What is Germany's rank by Synthetic biology investment?
Germany ranks #19 out of 197 countries in the world ranking by «Synthetic biology investment».
How has Synthetic biology investment changed in Germany?
Over the available period the indicator changed from 10 M to 120 M $.